AANS Online Scientific Session: Socioeconomic-Thirty - and 90 - Day Readmissions after Treatment of Traumatic Subdural Hematoma: A National Trend Analysis

Thirty - and 90 - Day Readmissions after Treatment of Traumatic Subdural Hematoma: A National Trend Analysis

Video Transcription

Video Summary

In this video, Andrew Koo, an intern for the Department of Neurosurgery at Yale, presents a study on readmissions in the traumatic subdural hematoma population. The study aims to identify patient factors associated with increased risk of unplanned readmissions and investigate the similarities and differences in risk factors for 30- and 90-day readmissions. The retrospective cohort study used the HCUP Nationwide Readmission Database and included 14,355 patients. The study found a 21.6% unplanned readmission rate after treatment of traumatic subdural hematoma, with infection, sepsis, and epilepsy-related complications being the most common drivers. Factors such as Medicare, Medicaid, hypertension, diabetes, renal failure, congestive heart failure, and coagulopathy were associated with increased 30-day readmission, while Medicare and rheumatoid arthritis or collagen vascular diseases were associated with increased 31- to 90-day readmission. The study concludes that reducing the burden of unplanned readmissions requires knowledge of these factors.

Asset Subtitle

Aladine Abdalla Elsamadicy, BE, MD

Keywords

readmissions

traumatic subdural hematoma

patient factors

unplanned readmissions

retrospective cohort study